Can Microfluidics Simulate Life? Exploring the Fusion of Organ-on-a-Chip and Droplet Platforms
Traditional drug screening and disease modeling—long reliant on 2D cell cultures and animal models—are increasingly criticized for their limited predictive power and inefficiency. As the demand for personalized medicine and high-throughput testing grows, researchers face a critical question: How can we build more realistic, scalable, and responsive in vitro systems?  ...
0 Comentários 0 Compartilhamentos 22 Visualizações 0 Anterior
Patrocinado
Patrocinado
Patrocinado
google-site-verification: google037b30823fc02426.html